SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-23-001027
Filing Date
2023-11-01
Accepted
2023-11-01 17:08:56
Documents
2
Group Members
ORBIMED ADVISORS II LTDORBIMED ADVISORS LTDORBIMED ASIA GP II, L.P.ORBIMED ASIA GP, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss2665315_sc13da.htm SC 13D/A 152239
2 JOINT FILING AGREEMENT ss2665315_ex9901.htm EX-99.1 7950
  Complete submission text file 0000947871-23-001027.txt   161816
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Subject) CIK: 0001944885 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94041 | Film No.: 231369141
SIC: 2834 Pharmaceutical Preparations